AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Cabotegravir Sodium in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| APRETUDE PROLONGED RELEASE SUSPENSION FOR INJECTION Prolonged release suspension for injection | Rwanda FDA-HMP-MA-1504 | GLAXO OPERATIONS UK LIMITED | active | 26 Jul 2029 |
Cabotegravir Sodium — RDA Registration Details
RDA (Rwanda) has 1 registered product containing Cabotegravir Sodium, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Cabotegravir Sodium registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.